Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

Signal Transduct Target Ther. 2022 Jun 4;7(1):178. doi: 10.1038/s41392-022-01040-9.

Authors

Longlong Liu¹, Pradeep Kumar Patnana¹, Subbaiah Chary Nimmagadda²

Affiliations

¹ Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany.
² Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany. [email protected].

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

AMP-Activated Protein Kinases / genetics
Lysosomes
Metformin* / pharmacology

Substances

Metformin
AMP-Activated Protein Kinases